{"id":"indomethacin-suppository","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Gastrointestinal irritation or ulceration"},{"rate":"5-15","effect":"Dyspepsia"},{"rate":"5-10","effect":"Headache"},{"rate":"3-9","effect":"Dizziness"},{"rate":"3-9","effect":"Nausea"},{"rate":"5-10","effect":"Rectal irritation (suppository formulation)"},{"rate":null,"effect":"Increased cardiovascular risk (chronic use)"},{"rate":null,"effect":"Renal impairment (chronic use)"}]},"_chembl":{"chemblId":"CHEMBL3989410","moleculeType":"Small molecule","molecularWeight":"433.82"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a non-selective nonsteroidal anti-inflammatory drug (NSAID), indomethacin blocks both COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins that mediate inflammatory responses, pain signaling, and fever regulation. The suppository formulation delivers the drug rectally for systemic absorption, providing anti-inflammatory and analgesic effects. This mechanism makes it effective for various inflammatory and pain conditions.","oneSentence":"Indomethacin inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:48:36.578Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Ankylosing spondylitis"},{"name":"Acute pain and inflammation"},{"name":"Patent ductus arteriosus (in neonates)"},{"name":"Migraine headache"}]},"trialDetails":[{"nctId":"NCT07495111","phase":"NA","title":"Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2025-12-01","conditions":"Cholelithiasis Associated With Common Bile Duct Stones","enrollment":88},{"nctId":"NCT05602246","phase":"NA","title":"Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS","status":"RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2022-12-01","conditions":"Pelvic Organ Prolapse, Cystocele, Cystocele and Incomplete Uterovaginal Prolapse","enrollment":592},{"nctId":"NCT07329790","phase":"","title":"Indian National Study to Assess Incidence and Severity of Post-ERCP Pancreatitis After Following SOP","status":"NOT_YET_RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2026-01-10","conditions":"ERCP","enrollment":2366},{"nctId":"NCT07088757","phase":"PHASE4","title":"Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-09-15","conditions":"Post-ERCP Pancreatitis","enrollment":1366},{"nctId":"NCT07202559","phase":"NA","title":"Aggressive Intravenous Hydration With or Without Indometacin to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-12-01","conditions":"Pancreatitis, Chronic, Pancreatitis, Acute, Pancreatic Duct Stones","enrollment":1250},{"nctId":"NCT05381428","phase":"PHASE3","title":"Prophylaxis of Post-ERCP Acute Pancreatitis","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2022-05-13","conditions":"Pancreatitis, Acute","enrollment":184},{"nctId":"NCT03547232","phase":"PHASE4","title":"Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-12-01","conditions":"Acute Pancreatitis, Complication, Mortality Rate","enrollment":1504},{"nctId":"NCT06837831","phase":"NA","title":"Efficacy of Mepilex Lite Dressings in Treating Anal Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Qianfoshan Hospital","startDate":"2024-12-06","conditions":"Rectal Cancer, Radiotherapy, Anal Pain","enrollment":196},{"nctId":"NCT04410536","phase":"PHASE4","title":"Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2020-06-15","conditions":"Migraine, Hemicrania","enrollment":25},{"nctId":"NCT06623513","phase":"PHASE2","title":"Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-10-01","conditions":"Pancreatitis, Acute, Cholangiopancreatography, Endoscopic Retrograde","enrollment":100},{"nctId":"NCT06031363","phase":"NA","title":"The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-11-01","conditions":"Pancreatitis, Cholangiopancreatography, Endoscopic Retrograde, Indomethacin","enrollment":192},{"nctId":"NCT05572788","phase":"NA","title":"Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts","status":"UNKNOWN","sponsor":"Orlando Health, Inc.","startDate":"2022-09-26","conditions":"Pancreatic Cyst, Pancreatitis, Acute","enrollment":600},{"nctId":"NCT02183168","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2001-07-01","conditions":"Spondylitis, Ankylosing","enrollment":192},{"nctId":"NCT05637281","phase":"NA","title":"Clinical Efficacy of Indomethacin in Early Treatment of Acute Pancreatitis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-12-11","conditions":"Acute Pancreatitis, Systemic Inflammatory Response Syndrome","enrollment":188},{"nctId":"NCT05722548","phase":"PHASE2","title":"Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2023-02-01","conditions":"Pancreatectomy","enrollment":200},{"nctId":"NCT05109143","phase":"NA","title":"Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-10-17","conditions":"Pancreatoduodenectomy","enrollment":44},{"nctId":"NCT02797067","phase":"PHASE4","title":"Rectal Indomethacin to Prevent Post ESWL-pancreatitis","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2016-05-31","conditions":"Pancreatitis","enrollment":1370},{"nctId":"NCT03643900","phase":"NA","title":"The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis","status":"COMPLETED","sponsor":"First People's Hospital of Hangzhou","startDate":"2018-08-08","conditions":"Post-ERCP Pancreatitis, Pancreatitis, Acute Necrotizing","enrollment":618},{"nctId":"NCT04964180","phase":"NA","title":"Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"South Valley University","startDate":"2020-05-01","conditions":"Post-Operative Pain","enrollment":80},{"nctId":"NCT02692391","phase":"PHASE3","title":"A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-07","conditions":"Acute Pancreatitis","enrollment":42},{"nctId":"NCT02959112","phase":"NA","title":"Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography","status":"TERMINATED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2016-05","conditions":"Pancreatitis, Acute","enrollment":548},{"nctId":"NCT03533803","phase":"PHASE3","title":"Indomethacin Prior to Difficult Embryo Transfer is it a Solution?","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-06-02","conditions":"Difficult Embryo Transfer","enrollment":200},{"nctId":"NCT03708458","phase":"PHASE4","title":"Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis","status":"UNKNOWN","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2017-04-01","conditions":"Post-ERCP Pancreatitis","enrollment":250},{"nctId":"NCT03629600","phase":"PHASE2, PHASE3","title":"Trial of Aggressive Hydration Versus Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2017-10-15","conditions":"Post-ERCP Acute Pancreatitis","enrollment":352},{"nctId":"NCT02641561","phase":"PHASE3","title":"Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis","status":"COMPLETED","sponsor":"The Cooper Health System","startDate":"2014-10","conditions":"Post-ERCP Acute Pancreatitis","enrollment":192},{"nctId":"NCT02111707","phase":"PHASE4","title":"Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2014-04","conditions":"Acute Pancreatitis","enrollment":534},{"nctId":"NCT02711358","phase":"PHASE4","title":"Indomethacin Use in Pain Relief During Intrauterine Device Insertion","status":"COMPLETED","sponsor":"Assiut University","startDate":"2016-03","conditions":"Family Planning","enrollment":120},{"nctId":"NCT01774604","phase":"PHASE3","title":"Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis","status":"TERMINATED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2013-01","conditions":"Post-ERCP Acute Pancreatitis","enrollment":449},{"nctId":"NCT02642601","phase":"PHASE2, PHASE3","title":"Role of Indomethacin in Difficult Embryo Transfer.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2014-03","conditions":"Difficult Embryo Transfer","enrollment":100},{"nctId":"NCT02368795","phase":"NA","title":"Non-inferiority of Pharmacological Prevention Alone Versus Pancreatic Stents to Prevent Post-ERCP Pancreatitis","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2015-02","conditions":"Pancreatitis","enrollment":400},{"nctId":"NCT02577809","phase":"PHASE4","title":"Intrathecal Opioid Study","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2015-07","conditions":"Post-operative Pain","enrollment":100},{"nctId":"NCT02110810","phase":"PHASE3","title":"Indomethacin Decreases Post-ERCP Pancreatitis","status":"COMPLETED","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2014-01","conditions":"Post ERCP Acute Pancreatitis","enrollment":160},{"nctId":"NCT00820612","phase":"PHASE4","title":"Rectal Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High Risk Patients","status":"TERMINATED","sponsor":"University of Michigan","startDate":"2009-01","conditions":"Post-ERCP Pancreatitis","enrollment":602},{"nctId":"NCT01742689","phase":"PHASE3","title":"Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2012-03","conditions":"Renal Colic, Pain","enrollment":88},{"nctId":"NCT01073670","phase":"PHASE4","title":"Indomethacin and Cardiac Bypass Surgery","status":"COMPLETED","sponsor":"Queen's University","startDate":"2000-08","conditions":"Hemorrhage","enrollment":82}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"ALANINE AMINOTRANSFERASE INCREASED"},{"count":2,"reaction":"ANAEMIA"},{"count":2,"reaction":"BLOOD ALKALINE PHOSPHATASE INCREASED"},{"count":2,"reaction":"GAMMA-GLUTAMYLTRANSFERASE INCREASED"},{"count":2,"reaction":"HYPERURICAEMIA"},{"count":2,"reaction":"HYPOCALCAEMIA"},{"count":2,"reaction":"HYPOKALAEMIA"},{"count":2,"reaction":"HYPOMAGNESAEMIA"},{"count":2,"reaction":"MYELOSUPPRESSION"},{"count":2,"reaction":"NEUTROPHIL COUNT DECREASED"}],"_approvalHistory":[],"publicationCount":54,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Indomethacin","Indocid suppository","Indocin","Indocid","Indochron"],"phase":"marketed","status":"active","brandName":"Indomethacin suppository","genericName":"Indomethacin suppository","companyName":"Azienda USL Reggio Emilia - IRCCS","companyId":"azienda-usl-reggio-emilia-irccs","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Indomethacin suppository is a small molecule that acts as a cyclooxygenase inhibitor, which is a class of drugs that inhibit the enzyme cyclooxygenase. It has been studied for various conditions including pain, renal colic, and post-operative pancreatitis, among others.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-04-20T00:00:00.000Z","mah":"RISING","brand_name_local":"INDOMETHACIN","application_number":"NDA018858"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-05-04T00:00:00.000Z","mah":"IVAX SUB TEVA PHARMS","brand_name_local":"INDOMETHACIN","application_number":"NDA018730"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-05-18T00:00:00.000Z","mah":"HERITAGE","brand_name_local":"INDOMETHACIN","application_number":"NDA018851"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-08-06T00:00:00.000Z","mah":"CHARTWELL MOLECULES","brand_name_local":"INDOMETHACIN","application_number":"NDA018829"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1985-09-04T00:00:00.000Z","mah":"RISING","brand_name_local":"INDOMETHACIN","application_number":"ANDA070624"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1985-10-18T00:00:00.000Z","mah":"DURAMED PHARMS BARR","brand_name_local":"INDOMETHACIN","application_number":"ANDA070327"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1985-10-18T00:00:00.000Z","mah":"DURAMED PHARMS BARR","brand_name_local":"INDOMETHACIN","application_number":"ANDA070326"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1986-02-12T00:00:00.000Z","mah":"HERITAGE PHARMA","brand_name_local":"INDOMETHACIN","application_number":"ANDA070719"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1986-02-12T00:00:00.000Z","mah":"HERITAGE PHARMA","brand_name_local":"INDOMETHACIN","application_number":"ANDA070756"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1986-03-05T00:00:00.000Z","mah":"CHARTWELL MOLECULES","brand_name_local":"INDOMETHACIN","application_number":"ANDA070651"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1986-10-03T00:00:00.000Z","mah":"MUTUAL PHARM","brand_name_local":"INDOMETHACIN","application_number":"ANDA070068"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1986-10-03T00:00:00.000Z","mah":"MUTUAL PHARM","brand_name_local":"INDOMETHACIN","application_number":"ANDA070067"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1986-10-10T00:00:00.000Z","mah":"SUPERPHARM","brand_name_local":"INDOMETHACIN","application_number":"ANDA070488"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-03-18T00:00:00.000Z","mah":"HIKMA","brand_name_local":"INDOMETHACIN","application_number":"ANDA071412"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-03-18T00:00:00.000Z","mah":"ANI PHARMS","brand_name_local":"INDOMETHACIN","application_number":"ANDA071148"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-03-18T00:00:00.000Z","mah":"ANI PHARMS","brand_name_local":"INDOMETHACIN","application_number":"ANDA071149"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-04-29T00:00:00.000Z","mah":"SANDOZ","brand_name_local":"INDOMETHACIN","application_number":"ANDA070674"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-04-29T00:00:00.000Z","mah":"SANDOZ","brand_name_local":"INDOMETHACIN","application_number":"ANDA070673"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1988-04-18T00:00:00.000Z","mah":"TEVA","brand_name_local":"INDOMETHACIN","application_number":"ANDA071342"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1988-04-18T00:00:00.000Z","mah":"TEVA","brand_name_local":"INDOMETHACIN","application_number":"ANDA071343"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1991-07-31T00:00:00.000Z","mah":"WATSON LABS","brand_name_local":"INDOMETHACIN","application_number":"ANDA072997"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1991-07-31T00:00:00.000Z","mah":"WATSON LABS","brand_name_local":"INDOMETHACIN","application_number":"ANDA072996"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1992-08-31T00:00:00.000Z","mah":"COSETTE","brand_name_local":"INDOMETHACIN","application_number":"ANDA073314"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2002-02-06T00:00:00.000Z","mah":"ABLE","brand_name_local":"INDOMETHACIN","application_number":"ANDA076114"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2003-12-17T00:00:00.000Z","mah":"ABLE","brand_name_local":"INDOMETHACIN","application_number":"ANDA076666"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2009-03-06T00:00:00.000Z","mah":"AVANTHI INC","brand_name_local":"INDOMETHACIN","application_number":"ANDA079175"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2010-03-17T00:00:00.000Z","mah":"FRESENIUS KABI USA","brand_name_local":"INDOMETHACIN","application_number":"NDA022536"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2010-12-01T00:00:00.000Z","mah":"AMNEAL PHARMS","brand_name_local":"INDOMETHACIN","application_number":"ANDA091549"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2010-12-22T00:00:00.000Z","mah":"GLENMARK PHARMS LTD","brand_name_local":"INDOMETHACIN","application_number":"ANDA091276"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2011-04-12T00:00:00.000Z","mah":"HETERO LABS LTD III","brand_name_local":"INDOMETHACIN","application_number":"ANDA091240"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2012-09-28T00:00:00.000Z","mah":"HETERO LABS LTD III","brand_name_local":"INDOMETHACIN","application_number":"ANDA201807"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-12-09T00:00:00.000Z","mah":"WATSON LABS INC","brand_name_local":"INDOMETHACIN","application_number":"ANDA202572"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2014-03-20T00:00:00.000Z","mah":"MYLAN","brand_name_local":"INDOMETHACIN","application_number":"ANDA202139"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2015-10-05T00:00:00.000Z","mah":"JUBILANT GENERICS","brand_name_local":"INDOMETHACIN","application_number":"ANDA202706"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2016-12-27T00:00:00.000Z","mah":"AUROBINDO PHARMA","brand_name_local":"INDOMETHACIN","application_number":"ANDA204243"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2017-05-08T00:00:00.000Z","mah":"NOVAST LABS","brand_name_local":"INDOMETHACIN","application_number":"ANDA204853"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2017-08-25T00:00:00.000Z","mah":"JUBILANT GENERICS","brand_name_local":"INDOMETHACIN","application_number":"ANDA205215"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2017-09-25T00:00:00.000Z","mah":"ZYDUS PHARMS","brand_name_local":"INDOMETHACIN","application_number":"ANDA202711"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2023-08-02T00:00:00.000Z","mah":"ZYDUS LIFESCIENCES","brand_name_local":"INDOMETHACIN","application_number":"ANDA216184"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2024-01-12T00:00:00.000Z","mah":"NOVITIUM PHARMA","brand_name_local":"INDOMETHACIN","application_number":"ANDA217883"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2025-02-24T00:00:00.000Z","mah":"AMNEAL","brand_name_local":"INDOMETHACIN","application_number":"ANDA215399"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2025-07-03T00:00:00.000Z","mah":"ANNORA PHARMA","brand_name_local":"INDOMETHACIN","application_number":"ANDA216905"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"HALSEY","brand_name_local":"INDOMETHACIN","application_number":"ANDA070782"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"WATSON LABS","brand_name_local":"INDOMETHACIN","application_number":"ANDA070785"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"SUPERPHARM","brand_name_local":"INDOMETHACIN","application_number":"ANDA070487"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PIONEER PHARMS","brand_name_local":"INDOMETHACIN","application_number":"ANDA070813"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"WATSON LABS","brand_name_local":"INDOMETHACIN","application_number":"ANDA070530"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"WATSON LABS","brand_name_local":"INDOMETHACIN","application_number":"ANDA070529"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PARKE DAVIS","brand_name_local":"INDOMETHACIN","application_number":"NDA018806"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"CYCLE","brand_name_local":"INDOMETHACIN","application_number":"ANDA070353"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"WATSON LABS","brand_name_local":"INDOMETHACIN","application_number":"NDA018690"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"HALSEY","brand_name_local":"INDOMETHACIN","application_number":"ANDA070635"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"CYCLE","brand_name_local":"INDOMETHACIN","application_number":"ANDA070354"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"WATSON LABS","brand_name_local":"INDOMETHACIN","application_number":"ANDA070784"}],"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}